【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ SD Specialized disclosure report Accession Number: 0001193125-24-150322 Act: 34 Size: 246 KB 网页链接
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007073 Act: 34 Size: 7 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006909 Act: 34 Size: 454 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-24-006907 Act: 34 Size: 149 KB 网页链接
$Neuronetics(STIM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-019355 Act: 34 Size: 3 MB 网页链接
$Neuronetics(STIM)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-019350 Act: 34 Size: 2 MB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-002306 Act: 34 Size: 124 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-080551 Act: 34 Size: 139 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-076600 Act: 34 Size: 139 KB 网页链接
$Neuronetics(STIM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002772 Act: 34 Size: 12 MB 网页链接